Tuesday, July 25, 2017

Celgene to Pay $280 Million to Settle Fraud Suit Over Cancer Drugs


By KATIE THOMAS from NYT Health Celgene to Pay $280 Million to Settle Fraud Suit Over Cancer Drugs
The lawsuit accused the pharmaceutical company of marketing Thalomid and Revlimid for unapproved use on a broader range of cancers. Read more article at hafana

No comments:

Post a Comment